Key Words For Korean Pharma In 2010s: Novelty, Open Innovation, Global Markets
Industry Pursues More Originality
Executive Summary
From being generics-focused to becoming innovators and leaders in biosimilars, Scrip takes a look at how the Korean pharma sector and environment have evolved over the past 10 years.